The use of human ovarian responsiveness in a new bioassay for follicle-stimulating hormone.
D000818:Animals; D001681:Biological Assay; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D004412:Dysmenorrhea / Q000188:drug therapy; D004967:Estrogens / Q000652:urine; D005260:Female; D005640:Follicle Stimulating Hormone / Q000032:analysis*; D006065:Gonadotropins, Pituitary / Q000627:therapeutic use*; D006207:Half-Life; D006801:Humans; D007986:Luteinizing Hormone / Q000032:analysis; D010060:Ovulation / Q000187:drug effects*; D011276:Pregnanediol / Q000652:urine; D011863:Radioimmunoassay; D051381:Rats
D006063:Chorionic Gonadotropin; D004967:Estrogens; D006065:Gonadotropins, Pituitary; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D011276:Pregnanediol